Clinical Trial

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated January 2, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be analyzed via a number of demographic lenses in order to find trends that could benefit future ALS sufferers.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05423678
Lead Sponsor Power Life Sciences Inc.
Conditions ALS, Amyotrophic Lateral Sclerosis
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-01-02